Martin J. van den Bent

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 33 papers. Top paper: “Evidence-based recommendations on categories for extent of resection in diffuse glioma”.

Evidence-based recommendations on categories for extent of resection in diffuse glioma

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.002

N/A

6.8DataRank · unranked

210 citations

Michael A. Vogelbaum, Martin J. van den Bent, Daniel P. Cahill, Lorenzo Bello, Yoshitaka Narita +4 more

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

The Lancet Oncology(2009)10.1016/s1470-2045(09)70025-7

N/A

1.3DataRank · unranked

7738 citations

Monika E. Hegi, Martin J. van den Bent, Martin JB Taphoorn, Robert C. Janzer, Samuel K. Ludwin +25 more

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

Acta Neuropathologica(2020)10.1007/s00401-020-02127-9

N/A

0.944DataRank · unranked

540 citations

Kenneth Aldape, Howard Colman, Dominique Figrarella-Branger, Gregory N. Fuller, Caterina Giannini +15 more

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

Neuro-Oncology(2020)10.1093/neuonc/noaa141

N/A

0.794DataRank · unranked

198 citations

C. Chad Quarles, Leland Hu, Bradley J. Erickson, Elizabeth R. Gerstner, Marion Smits +26 more

Diffuse Infiltrating Oligodendroglioma and Astrocytoma

Journal of Clinical Oncology(2017)10.1200/jco.2017.72.6737

N/A

0.772DataRank · unranked

171 citations

Marion Smits, Johan M. Kros, Susan M. Chang, Martin J. van den Bent

The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab035

N/A

0.724DataRank · unranked

14 citations

Quinn T. Ostrom, Shelley M. Pressley, Jennie Taylor, Alissa A. Thomas, Jeffrey S. Wefel +23 more

Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

Nature Reviews Clinical Oncology(2023)10.1038/s41571-023-00756-z

N/A

0.683DataRank · unranked

94 citations

Rupert Bartsch, Émilie Le Rhun, Anna S. Berghoff, Priscilla K. Brastianos, Javier Cortés +8 more

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report

The Lancet Oncology(2020)10.1016/s1470-2045(19)30796-x

N/A

0.661DataRank · unranked

81 citations

Linda Dirven, David Arons, Amanda Bates, Susan M. Chang, Corneel Coens +12 more

A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2225

N/A

0.644DataRank · unranked

72 citations

Patrick Y. Wen, Martin J. van den Bent, Scott R. Plotkin, Annemiek Walenkamp, Adam L. Green +13 more

EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors

Neuro-Oncology(2022)10.1093/neuonc/noac188

N/A

0.639DataRank · unranked

70 citations

David Capper, Adam Waldman, Johan Pallud, Giuseppe Minniti, Thomas Kaley +15 more

The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

Cancer Research(2023)10.1158/0008-5472.can-23-2093

N/A

0.609DataRank · unranked

57 citations

Thaís S. Sabedot, Natalia S. Morosini, Indrani Datta, Luciano Garofano, Wies Vallentgoed +67 more

Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033

Neuro-Oncology(2020)10.1093/neuonc/noaa252

N/A

0.606DataRank · unranked

56 citations

A Josephine Drijver, Martin J. van den Bent, Jacoline E. C. Bromberg, Khê Hoang‐Xuan, Martin J B Taphoorn +13 more

Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival

Neuro-Oncology(2023)10.1093/neuonc/noad002

N/A

0.578DataRank · unranked

46 citations

Patrick Y. Wen, Susan M. Chang, Martin J. van den Bent, Michael A. Vogelbaum, Gang Li +11 more

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

Neuro-Oncology(2020)10.1093/neuonc/noaa015

N/A

0.561DataRank · unranked

41 citations

Michael Weller, Joohee Sul, Stephen Bagley, Solmaz Sahebjam, Martin J. van den Bent +19 more

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

British Journal of Cancer(2023)10.1038/s41416-023-02402-y

N/A

0.553DataRank · unranked

39 citations

Anne Kleijn, Jie Ju, Kevin Jimenez-Cowell, Federica Fabro, Michelle Klein +35 more

Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas

The Lancet Oncology(2025)10.1016/s1470-2045(25)00193-7

N/A

0.542DataRank · unranked

36 citations

Philipp Lohmann, Mariam Aboian, Ramon Barajas, William G. Breen, Jana Ivanidze +29 more

A Neuroradiologist’s Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults

American Journal of Neuroradiology(2024)10.3174/ajnr.a8396

N/A

0.533DataRank · unranked

34 citations

Francesco Sanvito, Timothy F. Cloughesy, Raymond Y. Huang, Javier Villanueva-Meyer, Whitney B. Pope +21 more

Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors

Neuro-Oncology(2022)10.1093/neuonc/noac086

N/A

0.477DataRank · unranked

23 citations

Elizabeth R. Gerstner, Andrew B. Lassman, Caroline Chung, Howard Colman, Patricia E. Cole +21 more

A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group

The Lancet Oncology(2025)10.1016/s1470-2045(25)00534-0

N/A

0.449DataRank · unranked

19 citations

Jacob S. Young, Maarten M.J. Wijnenga, Tommaso Sciortino, Nico Teske, Alba Corell +44 more

Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials

Neuro-Oncology(2020)10.1093/neuonc/noaa253

N/A

0.449DataRank · unranked

19 citations

Matthew S. Brown, Jerrold L. Boxerman, Elizabeth R. Gerstner, Timothy J. Kaufmann, Patricia E. Cole +10 more

Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group

Neuro-Oncology(2024)10.1093/neuonc/noae231

N/A

0.434DataRank · unranked

17 citations

Jacob S. Young, Gilbert C Youssef, Antonio Dono, Levin Häni, Tommaso Sciortino +25 more

Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report

Neuro-Oncology(2025)10.1093/neuonc/noaf118

N/A

0.411DataRank · unranked

8 citations

Michael A. Vogelbaum, Timothy F. Cloughesy, Norbert Galldiks, Nathalie L. Albert, Joerg-Christian Tonn +30 more

Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study

Neuro-Oncology Practice(2025)10.1093/nop/npae091

N/A

0.269DataRank · unranked

5 citations

Abigirl Machingura, Martin J. van den Bent, Corneel Coens, Andrew Bottomley, Alba A Brandes +8 more

RANO seizure working group-Tumor-Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice

Neuro-Oncology(2025)10.1093/neuonc/noaf165

N/A

0.241DataRank · unranked

4 citations

Anne S. Reiner, Terri S. Armstrong, Ashley Aaroe, Elizabeth Cunningham, Julia Brown +20 more

The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.09.455687

N/A

0.165DataRank · unranked

2 citations

Thaís S. Sabedot, Indrani Datta, Luciano Garofano, Wies Vallentgoed, Frederick S. Varn +35 more

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline

Journal of Clinical Oncology(2021)10.1200/jco.21.02036

N/A

0DataRank · unranked

191 citations

Hans Messersmith, Na Tosha Gatson, Andreas F. Hottinger, Andrew B. Lassman, Jordan Morton +14 more

What is a glioblastoma?

Neuro-Oncology(2023)10.1093/neuonc/noad044

N/A

0DataRank · unranked

14 citations

Martin J. van den Bent, Andrew B. Lassman

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative

Neuro-Oncology(2025)10.1093/neuonc/noaf108

N/A

0DataRank · unranked

0 citations

Linda Dirven, Tobias Walbert, Terri S. Armstrong, David Arons, Martin J. van den Bent +24 more

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Neuro-Oncology(2020)10.1093/neuonc/noaa168

N/A

0DataRank · unranked

116 citations

Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis, Paul D. Brown +18 more

“Real world” use of a highly reliable imaging sign: “T2-FLAIR mismatch” for identification of IDH mutant astrocytomas

Neuro-Oncology(2020)10.1093/neuonc/noaa041

N/A

0DataRank · unranked

137 citations

Derek R. Johnson, Sohil H. Patel, Maurício Castillo, Marion Smits, Martin J. van den Bent +3 more

State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond

American Society of Clinical Oncology Educational Book(2024)10.1200/edbk_431450

N/A

0DataRank · unranked

19 citations

Μαρία Ιωάννου, Marjolein Geurts, Martin J. van den Bent, Ingo K. Mellinghoff, Karisa C. Schreck +1 more

Reproducible radiomics through automated machine learning validated on twelve clinical applications

arXiv (Cornell University)(2021)10.48550/arxiv.2108.08618

N/A

0DataRank · unranked

1 citations

Sebastian R. van der Voort, Thomas Phil, Milea J. M. Timbergen, Melissa Vos, Guillaume A. Padmos +41 more

Malignant glioma in L-2-Hydroxy Glutaric Aciduria: thorough molecular characterization of a case and literature review

PubMed(2024)10.17879/freeneuropathology-2024-5377

N/A

0DataRank · unranked

2 citations

Pieter Wesseling, Bastiaan B.J. Tops, Lennart Kester, Pim J. French, Martin J. van den Bent +7 more